Ignite Creation Date:
2024-05-06 @ 7:55 AM
Last Modification Date:
2024-10-26 @ 11:54 AM
Study NCT ID:
NCT02632045
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-06
First Post:
2015-12-14
Brief Title:
Study of Efficacy of Ribociclib After Progression on CDK46 Inhibition in Patients With HR HER2- Advanced Breast Cancer
Sponsor:
Melissa K Accordino
Organization:
Columbia University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-10
Completion Date Type:
ESTIMATED
First Submit Date:
2015-12-14
First Submit QC Date:
December 15 2015
Study First Post Date:
2015-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-04
Last Update Post Date:
2023-10-06
Last Update Post Date Type:
ACTUAL